63 related articles for article (PubMed ID: 511973)
1. Cholesterol metabolism in diabetes: the effect of insulin on the kinetics of plasma squalene.
Frier BM; Saudek CD
J Clin Endocrinol Metab; 1979 Dec; 49(6):824-9. PubMed ID: 511973
[TBL] [Abstract][Full Text] [Related]
2. Measurement of cholesterol synthesis in man by isotope kinetics of squalene.
Liu GC; Ahrens EH; Schreibman PH; Samuel P; McNamara DJ; Crouse JR
Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4612-6. PubMed ID: 1060141
[TBL] [Abstract][Full Text] [Related]
3. Measurement of daily cholesterol synthesis rates in man by assay of the fractional conversion of mevalonic acid to cholesterol.
McNamara DJ; Ahrens EH; Samuel P; Crouse JR
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3043-6. PubMed ID: 268653
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different components in the fractional conversion of mevalonate to cholesterol with cholesterol synthesis and serum methyl sterols.
Miettinen TA; Tilvis R
Scand J Clin Lab Invest; 1981 Sep; 41(5):507-12. PubMed ID: 7313530
[TBL] [Abstract][Full Text] [Related]
5. Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.
McNamara DJ; Ahrens EH; Parker TS; Morrissey K
J Clin Invest; 1985 Jul; 76(1):31-9. PubMed ID: 4019781
[TBL] [Abstract][Full Text] [Related]
6. [Activities of 3-hydroxy-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and rate of biosynthesis of mevalonic acid, squalene, sterols and fatty acids from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: changes induced by daily rhythm].
Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
Biokhimiia; 1981 Jan; 46(1):126-39. PubMed ID: 6113851
[TBL] [Abstract][Full Text] [Related]
7. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes.
Simonen P; Gylling H; Miettinen TA
Atherosclerosis; 2008 Apr; 197(2):883-8. PubMed ID: 17875306
[TBL] [Abstract][Full Text] [Related]
8. Posthatching evolution of in vivo mevalonate metabolism in chick liver.
Aguilera JA; García-Molina V; Linares A; Arce V; García-Peregrin E
Biochem Int; 1987 Feb; 14(2):375-83. PubMed ID: 3579966
[TBL] [Abstract][Full Text] [Related]
9. Plasma squalene: lipoprotein distribution and kinetic analysis.
Saudek CD; Frier BM; Liu GC
J Lipid Res; 1978 Sep; 19(7):827-35. PubMed ID: 712242
[TBL] [Abstract][Full Text] [Related]
10. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes.
Simonen PP; Gylling H; Miettinen TA
Atherosclerosis; 2007 Sep; 194(1):222-9. PubMed ID: 16963050
[TBL] [Abstract][Full Text] [Related]
11. Studies of the in vivo metabolism of mevalonic acid in the normal rat.
Hellstrom KH; Siperstein MD; Bricker LA; Luby LJ
J Clin Invest; 1973 Jun; 52(6):1303-13. PubMed ID: 4703220
[TBL] [Abstract][Full Text] [Related]
12. Enhanced synthesis of cholesterol and its precursors in jejunal mucosa in coeliac disease.
Vuoristo M; Miettinen TA
Gut; 1986 Apr; 27(4):399-404. PubMed ID: 3957109
[TBL] [Abstract][Full Text] [Related]
13. Effects of diabetes mellitus on cholesterol metabolism in man.
Bennion LJ; Grundy SM
N Engl J Med; 1977 Jun; 296(24):1365-71. PubMed ID: 870827
[TBL] [Abstract][Full Text] [Related]
14. Fate of intravenously administered squalene in the rat.
Tilvis RS; Miettinen TA
Biochim Biophys Acta; 1982 Aug; 712(2):374-81. PubMed ID: 7126611
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
16. Visceral obesity is associated with high levels of serum squalene.
Peltola P; Pihlajamäki J; Koutnikova H; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kainulainen S; Gylling H; Miettinen TA; Auwerx J; Laakso M
Obesity (Silver Spring); 2006 Jul; 14(7):1155-63. PubMed ID: 16899796
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of cholesterol in rabbit reticulocytes and its exchange with plasma.
Sloviter HA; Janic V; Cirkovic T
J Lipid Res; 1970 Mar; 11(2):82-6. PubMed ID: 5418482
[TBL] [Abstract][Full Text] [Related]
18. Plasma squalene as an index of cholesterol synthesis.
Nestel PJ; Kudchodkar B
Clin Sci Mol Med; 1975 Dec; 49(6):621-4. PubMed ID: 1204294
[TBL] [Abstract][Full Text] [Related]
19. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
20. Squalene, lanosterol and cholesterol synthesis from acetate in neonatal chick tissues.
Linares A; Arce V; Aguilera JA; García-Peregrín E
Rev Esp Fisiol; 1984 Dec; 40(4):425-9. PubMed ID: 6531508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
